InspireMD's Mguard embolic protection stent has demonstrated a positive outcome in treating patients suffering heart attacks when compared to bare metal or drug-eluting stents during the study. The multi-center randomized MASTER ...
Tags: embolic protection stent, clinical trial, clinical technology
Brainsway has started the multicenter clinical trial of its Deep TMS device, designed to treat various neurological and psychopathological disorders. Noninvasive Deep TMS device has also the potential to treat schizophrenia, obesity, ...
Tags: Brainsway, Deep TMS device, Parkinson's disease, Alzheimer's disease
AbGenomics International, a biopharmaceutical company, has obtained FDA agreement on Its Phase 2 clinical trial plans of the novel autoimmune therapeutic candidate, AbGn-168H. The current Phase 2 AbGn-168H trial will be a multicenter, ...
Tags: FDA approval, psoriatic, clinical trial, pharmaceutical product
The United States Army Institute of Surgical Research (USAISR) has completed a clinical trial of OxyBand Technologies' OxyBand wound dressing, designed to deliver therapeutic pure oxygen to damaged tissue. By using a directional permeable ...
Tags: clinical study, wound dressing, cooperation, clinical technology
Accumetrics has received Health Canada license for its VerifyNow system, designed to measure platelet reactivity in patients on antiplatelet medications including aspirin and P2Y12 inhibitors (clopidogrel). As per the license, VerifyNow ...
Tags: VerifyNow system, platelet reactivity system, P2Y12 inhibitors, aspirin
AspenBio Pharma has submitted its AppyScore blood-based test's pre-investigational device exemption (pre-IDE) to the US Food and Drug Administration (FDA). AppyScore blood-based test is designed to aid physicians in identifying children ...
Tags: pre-investigational device, pre-IDE device, AppyScore blood-based test
ImageIQ, an imaging contract research organization, has entered into a collaboration agreement to provide imaging analytics for Histogenics' Phase 3 IND clinical trial of NeoCart implant. Histogenics said NeoCart is an autologous ...
Tags: ImageIQ, Histogenics, NeoCart
St Joseph Hospital has enrolled first patient for SYMPLICITY HTN-3 trial, conducted by Medtronic, designed to assess investigational Symplicity renal denervation system. Minimally invasive, catheter-based renal denervation procedure is ...
Tags: renal denervation system, catheter-based renal denervation
Syne qua non has introduced new electronic data capture (EDC) and clinical trial management solution, Syne-clin. Syne-clin, which has the capability to utilize new and emerging mobile technology, features multimedia, touch based ...
Tags: Syne-clin EDC Solution, electronic data capture solution
The US Patent and Trademark Office (USPTO) has issued a notice of allowance for CytRx Corporation's patent application covering a pharmaceutical composition of tamibarotene in capsule form. Tamibarotene is an orally available, ...
Tags: notice of allowance, patent application, tamibarotene, USPTO
US based Spectrum Pharmaceuticals has selected PharmaVigilant's I-Vault as its electronic Trial Master File (eTMF) Platform. I-Vault eTMF solution will be used to commence new Electronic Trial Master Files. PharmaVigilant founder and ...
ALung Technologies has presented data from Hemolung respiratory assist system's (RAS) clinical trial. The trial enrolled seven patients with acute exacerbation of chronic obstructive pulmonary disease (COPD) who were failing non-invasive ...
Tags: clinical trial, emolung respiratory assist system, COPD
Genewiz, a provider of DNA services, has obtained clinical laboratory improvement amendments (CLIA) certification. The certification allows the company to expand its clinical genomic testing solutions, thus contributing to advancements in ...
Tags: DNA services, CLIA Certification, clinical genomic testing
Emmaus Medical, a subsidiary of Emmaus Life Sciences, has received European orphan medicinal product designation for Levoglutamide (L-glutamine) for the treatment of sickle cell disease. Emmaus is at present conducting a trial, at over 30 ...
Tags: sickle cell disease, clinical trial, product designation
The US Food and Drug Administration (FDA) has granted a conditional investigational device exemption (IDE) approval to Edwards Lifesciences' new GLX technology platform. Based on the IDE approval, the company will commence a clinical ...
Tags: FDA, IDE, Lifesciences, GLX technology